Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 148 articles:
HTML format



Single Articles


    April 2021
  1. GOLOB JL, Rao K
    Signal vs. noise: how to analyze the microbiome and make progress on antimicrobial resistance.
    J Infect Dis. 2021 Apr 21. pii: 6242384. doi: 10.1093.
    PubMed    


    March 2021
  2. PRAZAK J, Valente L, Iten M, Federer L, et al
    Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA): an experimental study in rats.
    J Infect Dis. 2021 Mar 1. pii: 6154719. doi: 10.1093.
    PubMed     Abstract available


  3. RANALLO RT, Clifford McDonald L, Laufer Halpin A, Hiltke T, et al
    The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance.
    J Infect Dis. 2021 Mar 1. pii: 6154668. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  4. ANTHONY WE, Burnham CD, Dantas G, Kwon JH, et al
    The Gut Microbiome as a Reservoir for Antimicrobial Resistance.
    J Infect Dis. 2020 Dec 16. pii: 6039355. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  5. GUTHRIE JL, Teatero S, Hirai S, Fortuna A, et al
    Genomic Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Hospitalized Individuals in Ontario, Canada.
    J Infect Dis. 2020;222:2071-2081.
    PubMed     Abstract available


  6. CEHOVIN A, Jolley KA, Maiden MCJ, Harrison OB, et al
    Association of Neisseria gonorrhoeae Plasmids With Distinct Lineages and The Economic Status of Their Country of Origin.
    J Infect Dis. 2020;222:1826-1836.
    PubMed     Abstract available


    October 2020
  7. STRAY K, Perron M, Porter DP, Anderson F, et al
    Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
    J Infect Dis. 2020;222:1468-1477.
    PubMed     Abstract available


    August 2020
  8. JOHNSON MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, et al
    Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


    July 2020
  9. STRICH JR, Heil EL, Masur H
    Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  10. BUSCH LM, Kadri SS
    Antimicrobial Treatment Duration in Sepsis and Serious Infections.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  11. SEPTIMUS EJ
    Sepsis Perspective 2020.
    J Infect Dis. 2020;222.
    PubMed    


  12. KARAU MJ, Schmidt-Malan SM, Albano M, Mandrekar JN, et al
    Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis.
    J Infect Dis. 2020 Jul 7. pii: 5868461. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  13. CASTO AM, Stout SC, Selvarangan R, Freeman AF, et al
    Evaluation of Genotypic Antiviral Resistance Testing as an Alternative to Phenotypic Testing in a Patient with DOCK8 Deficiency and Severe HSV-1 Disease.
    J Infect Dis. 2020;221:2035-2042.
    PubMed     Abstract available


  14. KEBRIAEI R, Stamper KC, Singh KV, Khan A, et al
    Mechanistic Insights into the Differential Efficacy of Daptomycin plus beta-Lactam Combinations against Daptomycin-Resistant Enterococcus faecium.
    J Infect Dis. 2020 Jun 8. pii: 5854807. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  15. LONG SW
    The Ongoing Threat of Methicillin-resistant Staphylococcus aureus.
    J Infect Dis. 2020 May 20. pii: 5841128. doi: 10.1093.
    PubMed    


    April 2020
  16. MOHAMED M, Clabots C, Porter SB, Bender T, et al
    Large Fecal Reservoir of Escherichia coli Sequence Type 131-H30 Subclone Strains That Are Shared Within Households and Resemble Clinical ST131-H30 Isolates.
    J Infect Dis. 2020;221:1659-1668.
    PubMed     Abstract available


  17. LI L, Bayer AS, Cheung A, Lu L, et al
    The stringent response contributes to persistent methicillin-resistant Staphylococcus aureus endovascular infection through the purine biosynthetic pathway.
    J Infect Dis. 2020 Apr 25. pii: 5825247. doi: 10.1093.
    PubMed     Abstract available


  18. INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
    Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
    J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
    PubMed     Abstract available


  19. LI W, Tapiainen T, Brinkac L, Lorenzi HA, et al
    Vertical transmission of gut microbiome and antimicrobial resistance genes in infants exposed to antibiotics at birth.
    J Infect Dis. 2020 Apr 2. pii: 5814973. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  20. JI S, Jiang S, Wei X, Sun L, et al
    In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  21. CHEN H, Yin Y, Li X, Li S, et al
    Whole-Genome Analysis of Livestock-Associated Methicillin-Resistant Staphylococcus aureus Sequence Type 398 Strains Isolated From Patients With Bacteremia in China.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  22. XIAO T, Zhu Y, Zhang S, Wang Y, et al
    A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  23. LIU J, Zhang L, Pan J, Huang M, et al
    Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  24. DING B, Shen Z, Qin X, Yang Y, et al
    The Predominance of Strain Replacement Among Enterobacteriaceae Pairs With Emerging Carbapenem Resistance During Hospitalization.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  25. QIN X, Wu S, Hao M, Zhu J, et al
    The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  26. XIE J, Li S, Xue M, Yang C, et al
    Early- and Late-Onset Bloodstream Infections in the Intensive Care Unit: A Retrospective 5-Year Study of Patients at a University Hospital in China.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  27. XIAO M, Chen SC, Kong F, Xu XL, et al
    Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  28. XIAO Y, Shen P, Zheng B, Zhou K, et al
    Change in Antibiotic Use in Secondary and Tertiary Hospitals Nationwide After a National Antimicrobial Stewardship Campaign Was Launched in China, 2011-2016: An Observational Study.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  29. LIU B, Shui L, Zhou K, Jiang Y, et al
    Impact of Plasmid-Encoded H-NS-like Protein on blaNDM-1-Bearing IncX3 Plasmid in Escherichia coli.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  30. TONG L, Hu XG, Huang F, Huang SW, et al
    Clinical Impacts and Outcomes With Possible Donor-Derived Infection in Infected Donor Liver Transplantation: A Single-Center Retrospective Study in China.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  31. ZHANG X, Wang C, Feng Y, Long H, et al
    A Pandrug-Resistant Providencia Carrying Two blaIMP Carbapenemase-Encoding Genes Including blaIMP-69, a New blaIMP Variant, on a Newly Identified Worldwide-Distributed IncC Plasmid.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  32. HARRISON OB, Cehovin A, Skett J, Jolley KA, et al
    Neisseria gonorrhoeae Population Genomics: Use of the Gonococcal Core Genome to Improve Surveillance of Antimicrobial Resistance.
    J Infect Dis. 2020 Mar 12. pii: 5804212. doi: 10.1093.
    PubMed     Abstract available


  33. ACOSTA E, Bowlin T, Brooks J, Chiang L, et al
    Advances in the Development of Therapeutics for Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  34. MURRAY GL, Bodiyabadu K, Danielewski J, Garland SM, et al
    Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.
    J Infect Dis. 2020;221:1017-1024.
    PubMed     Abstract available


  35. GALLAGHER LA, Shears RK, Fingleton C, Alvarez L, et al
    Impaired Alanine Transport or Exposure to d-Cycloserine Increases the Susceptibility of MRSA to beta-lactam Antibiotics.
    J Infect Dis. 2020;221:1000-1016.
    PubMed     Abstract available


    February 2020
  36. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil susceptibility after treatment of children with influenza A during the 2018/2019 influenza season.
    J Infect Dis. 2020 Feb 8. pii: 5730526. doi: 10.1093.
    PubMed     Abstract available


  37. LEANSE LG, Dong PT, Goh XS, Lu M, et al
    Quinine Enhances Photo-Inactivation of Gram-Negative Bacteria.
    J Infect Dis. 2020;221:618-626.
    PubMed     Abstract available


    January 2020
  38. CLICK ES, Kurbatova E, Alexander H, Dalton TL, et al
    Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
    J Infect Dis. 2020 Jan 31. pii: 5718252. doi: 10.1093.
    PubMed     Abstract available


  39. TZOU PL, Descamps D, Rhee SY, Raugi DN, et al
    Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.
    J Infect Dis. 2020 Jan 22. pii: 5713448. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  40. MA K, Feng Y, Liu L, Yao Z, et al
    A cluster of colistin- and carbapenem-resistant Klebsiella pneumoniae carrying blaNDM-1 and mcr-8.2.
    J Infect Dis. 2019 Dec 11. pii: 5673084. doi: 10.1093.
    PubMed     Abstract available


  41. MBUNKAH HA, Bertagnolio S, Hamers RL, Hunt G, et al
    Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: A systematic review of detection methods, prevalence, and clinical impact.
    J Infect Dis. 2019 Dec 6. pii: 5664819. doi: 10.1093.
    PubMed     Abstract available


  42. JO H, Kwon DE, Han SH, Min SY, et al
    De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-infected Tissues: Implications for Primary Letermovir Resistance.
    J Infect Dis. 2019 Dec 5. pii: 5658434. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  43. DOUGLAS CM, Barnard R, Holder D, Leavitt R, et al
    Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.
    J Infect Dis. 2019 Nov 29. pii: 5645458. doi: 10.1093.
    PubMed     Abstract available


  44. SEMCHENKO EA, Mubaiwa TD, Day CJ, Seib KL, et al
    The gonococcal Neisserial Heparin Binding Antigen (NHBA) is involved in microcolony formation and contributes to serum resistance and adherence to epithelial cells.
    J Infect Dis. 2019 Nov 27. pii: 5644429. doi: 10.1093.
    PubMed     Abstract available


  45. GREGSON J, Rhee SY, Datir R, Pillay D, et al
    HIV-1 viral load is elevated in individuals with reverse transcriptase mutation M184V/I during virological failure of first line antiretroviral therapy and is associated with compensatory mutation L74I.
    J Infect Dis. 2019 Nov 27. pii: 5644529. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  46. GEORGHIOU SB, Schumacher SG, Rodwell TC, Colman RE, et al
    Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.
    J Infect Dis. 2019;220.
    PubMed     Abstract available


  47. WEISS E, Schlatterer K, Beck C, Peschel A, et al
    Formyl-peptide receptor activation enhances phagocytosis of community-acquired methicillin-resistant Staphylococcus aureus.
    J Infect Dis. 2019 Oct 1. pii: 5580022. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  48. CHESNOKOV A, Patel MC, Mishin VP, De La Cruz JA, et al
    Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir.
    J Infect Dis. 2019 Sep 21. pii: 5572441. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  49. CHECKMAHOMED L, M'hamdi Z, Carbonneau J, Venable MC, et al
    Impact of the baloxavir-resistant polymerase acid (PA) I38T substitution on the fitness of contemporary influenza A(H1N1)pdm09 and A(H3N2) strains.
    J Infect Dis. 2019 Aug 16. pii: 5550847. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  50. UEHARA T, Hayden FG, Kawaguchi K, Omoto S, et al
    Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
    J Infect Dis. 2019 Jul 16. pii: 5532607. doi: 10.1093.
    PubMed     Abstract available


  51. CATTOIR V, Felden B
    Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges.
    J Infect Dis. 2019;220:350-360.
    PubMed     Abstract available


    June 2019
  52. PIRET J, Schibler M, Pham VD, Hantz S, et al
    Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.
    J Infect Dis. 2019 Jun 13. pii: 5519111. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  53. BARTSCH SM, Wong KF, Stokes-Cawley OJ, McKinnell JA, et al
    Knowing More of the Iceberg: How Detecting a Greater Proportion of Carbapenem-Resistant Enterobacteriaceae (CRE) Carriers Impacts Transmission.
    J Infect Dis. 2019 May 31. pii: 5509628. doi: 10.1093.
    PubMed     Abstract available


  54. DUTCHER L, Lautenbach E
    A deeper dive: Implications of identifying more of the Carbapenem-resistant Enterobacteriaceae Iceberg.
    J Infect Dis. 2019 May 31. pii: 5509630. doi: 10.1093.
    PubMed    


  55. GANDHI RT, Tashima KT, Smeaton LM, Vu V, et al
    Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-week Results of AIDS Clinical Trials Group A5241 (OPTIONS).
    J Infect Dis. 2019 May 28. pii: 5499329. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  56. ABD EL-AZIZ AM, Elgaml A, Ali YM
    Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
    J Infect Dis. 2019;219:1439-1447.
    PubMed     Abstract available


  57. OLESEN SW, Grad YH
    Deciphering the impact of bystander selection for antibiotic resistance in Neisseria gonorrhoeae.
    J Infect Dis. 2019 Apr 8. pii: 5430789. doi: 10.1093.
    PubMed    


  58. HUANG CF, Hung CH, Cheng PN, Bair MJ, et al
    An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naive chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated subst
    J Infect Dis. 2019 Apr 8. pii: 5430846. doi: 10.1093.
    PubMed     Abstract available


  59. KENYON C, Buyze J, Spiteri G, Cole MJ, et al
    Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
    J Infect Dis. 2019 Apr 8. pii: 5430759. doi: 10.1093.
    PubMed     Abstract available


  60. RINCON S, Panesso D, Miller WR, Singh KV, et al
    Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils.
    J Infect Dis. 2019 Apr 2. pii: 5425477. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  61. ULLOA ER, Dillon N, Tsunemoto H, Pogliano J, et al
    Avibactam Sensitizes Carbapenem-Resistant NDM-1-Producing Klebsiella pneumoniae to Innate Immune Clearance.
    J Infect Dis. 2019 Mar 29. pii: 5421810. doi: 10.1093.
    PubMed     Abstract available


  62. CANCINO-MUNOZ I, Moreno-Molina M, Furio V, Goig GA, et al
    Cryptic resistance mutations associated to misdiagnoses of Multidrug-resistant tuberculosis.
    J Infect Dis. 2019 Mar 15. pii: 5381710. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  63. THOMAS JC, Seby S, Abrams AJ, Cartee J, et al
    Evidence of Recent Genomic Evolution in Gonococcal Strains with Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
    J Infect Dis. 2019 Feb 21. pii: 5351606. doi: 10.1093.
    PubMed     Abstract available


  64. ADAMS KN, Verma AK, Gopalaswamy R, Adikesavalu H, et al
    Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance.
    J Infect Dis. 2019 Feb 7. pii: 5308873. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  65. OLESEN SW, Torrone EA, Papp JR, Kirkcaldy RD, et al
    Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use.
    J Infect Dis. 2019;219:619-623.
    PubMed     Abstract available


  66. ADLER H, Nikolaou E, Gould K, Hinds J, et al
    Pneumococcal colonization in healthy adult research participants in the conjugate vaccine era, United Kingdom, 2010-2017.
    J Infect Dis. 2019 Jan 28. pii: 5303784. doi: 10.1093.
    PubMed     Abstract available


  67. WANG Y, Ferrer-Espada R, Baglo Y, Goh XS, et al
    Photo-inactivation of Neisseria gonorrhoeae: A paradigm changing approach for combating antibiotic-resistant gonococcal infection.
    J Infect Dis. 2019 Jan 9. pii: 5283517. doi: 10.1093.
    PubMed     Abstract available


  68. RAGHWANI J, Wu CH, Ho CKY, De Jong M, et al
    High resolution evolutionary analysis of within-host hepatitis C virus infection.
    J Infect Dis. 2019 Jan 2. pii: 5269822. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  69. LEE N, Ison MG
    Inhibiting Viral Polymerase and Neuraminidase in Treating Influenza.
    J Infect Dis. 2018 Nov 14. pii: 5183287. doi: 10.1093.
    PubMed    


  70. FINBERG RW, Lanno R, Anderson D, Fleischhackl R, et al
    Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
    J Infect Dis. 2018 Nov 14. pii: 5183286. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  71. GRILLOVA L, Noda AA, Lienhard R, Blanco O, et al
    Multilocus sequence typing of Treponema pallidum subsp. pallidum in Cuba from 2012 to 2017.
    J Infect Dis. 2018 Oct 16. pii: 5132979. doi: 10.1093.
    PubMed     Abstract available


  72. SUTHAR AB, Coggin W, Raizes E
    Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS.
    J Infect Dis. 2018 Oct 11. pii: 5126519. doi: 10.1093.
    PubMed    


    July 2018
  73. ZHANG WW, Cheung PK, Oliviera N, Robbins MA, et al
    Accumulation of multiple mutations in vivo confers cross-resistance to new and existing integrase inhibitors.
    J Infect Dis. 2018 Jul 16. pii: 5054084. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  74. BORGIA SM, Hedskog C, Parhy B, Hyland RH, et al
    Identification of a Novel Hepatitis C Virus Genotype from Punjab, India - Expanding Classification of Hepatitis C Virus into 8 Genotypes.
    J Infect Dis. 2018 Jun 30. pii: 5047409. doi: 10.1093.
    PubMed     Abstract available


  75. LI L, Abdelhady W, Donegan NP, Seidl K, et al
    Role of Purine Biosynthesis in Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Infection.
    J Infect Dis. 2018 Jun 2. pii: 5032510. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  76. PHAM HT, Labrie L, Wijting IEA, Hassounah S, et al
    The S230R Integrase Substitution Associated with Viral Rebound during DTG Monotherapy Confers Low Levels INSTI Drug Resistance.
    J Infect Dis. 2018 Mar 29. pii: 4956223. doi: 10.1093.
    PubMed     Abstract available


  77. WIJTING IEA, Lungu C, Rijnders BJA, van der Ende ME, et al
    HIV-1 resistance dynamics in patients failing dolutegravir maintenance monotherapy.
    J Infect Dis. 2018 Mar 29. pii: 4956224. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  78. LAMOTH F, Kontoyiannis DP
    The Candida auris Alert: Facts and Perspectives.
    J Infect Dis. 2018;217:516-520.
    PubMed    


  79. PIRES S, Jacquet R, Parker D
    Inducible Costimulator Contributes to Methicillin-Resistant Staphylococcus aureus Pneumonia.
    J Infect Dis. 2018 Jan 25. pii: 4825828. doi: 10.1093.
    PubMed     Abstract available


  80. BOUCHER HW, Ambrose PG, Chambers HF, Ebright RH, et al
    Reply to Paul and Leibovici.
    J Infect Dis. 2018;217:509-510.
    PubMed    


  81. PAUL M, Leibovici L
    Drug Development for Multidrug-Resistant Bacteria: Why Compromise?
    J Infect Dis. 2018;217:508-509.
    PubMed    


  82. CHEUNG GYC, Fisher EL, McCausland JW, Choi J, et al
    Antimicrobial peptide resistance mechanism contributes to Staphylococcus aureus infection.
    J Infect Dis. 2018 Jan 17. pii: 4812604. doi: 10.1093.
    PubMed     Abstract available


  83. GENDRIN C, Merillat S, Vornhagen J, Coleman M, et al
    Diminished capsule exacerbates virulence, blood brain barrier penetration, intracellular persistence and antibiotic evasion of hyperhemolytic Group B Streptococcus.
    J Infect Dis. 2018 Jan 2. pii: 4782479. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  84. STELLA-ASCARIZ N, Arribas JR, Paredes R, Li JZ, et al
    The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  85. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  86. RAIZES E, Hader S, Birx D
    Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


    November 2017
  87. ANDREI G, Gillemot S, Topalis D, Snoeck R, et al
    The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase.
    J Infect Dis. 2017 Nov 23. pii: 4653578. doi: 10.1093.
    PubMed     Abstract available


  88. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  89. BLOOMFIELD SJ, Midwinter AC, Biggs PJ, French NP, et al
    Long-term colonisation by Campylobacter jejuni within a human host: evolution, antimicrobial resistance and adaptation.
    J Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  90. SIBERRY GK, Amzel A, Ramos A, Rivadeneira ED, et al
    Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    J Infect Dis. 2017 Oct 17. doi: 10.1093.
    PubMed     Abstract available


  91. BERTAGNOLIO S, Beanland RL, Jordan MR, Doherty M, et al
    The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Abstract available


  92. DUARTE HA, Panpradist N, Beck IA, Lutz B, et al
    Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Abstract available


  93. SILVERMAN RA, Beck IA, Kiptinness C, Levine M, et al
    Prevalence of Pre-antiretroviral Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-infected Individuals Initiating Therapy in Kenya, 2013-2014.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    PubMed     Abstract available


  94. MINIOR T, Douglas M, Edgil D, Srivastava M, et al
    The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Abstract available


  95. ZHUKOVA A, Cutino-Moguel T, Gascuel O, Pillay D, et al
    The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Abstract available


  96. SINGH D, Dhummakupt A, Siems L, Persaud D, et al
    Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Abstract available


  97. CHUN HM, Obeng-Aduasare YF, Broyles LN, Ellenberger D, et al
    Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  98. CREANGA A, Hang NLK, Cuong VD, Nguyen HT, et al
    Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  99. GUBAREVA LV, Sleeman K, Guo Z, Yang H, et al
    Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  100. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    PubMed     Abstract available


  101. MOORE T, Dembry LM, Saag MS
    Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  102. NOGUERA-JULIAN M, Edgil D, Harrigan PR, Sandstrom P, et al
    Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Abstract available


  103. SHAFER RW
    Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Abstract available


  104. GODFREY C, Bobkova M, Boucher C, Ravasi G, et al
    Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Abstract available


  105. KISO M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R, et al
    Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.
    J Infect Dis. 2017;216:582-593.
    PubMed     Abstract available


    August 2017
  106. TUITE AR, Gift TL, Chesson HW, Hsu K, et al
    Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea.
    J Infect Dis. 2017 Aug 31. doi: 10.1093.
    PubMed     Abstract available


  107. OSTROSKY-ZEICHNER L, Andes D
    The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  108. LEWIS RE, Verweij PE
    Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  109. CHOWDHARY A, Sharma C, Meis JF
    Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  110. ARENDRUP MC, Patterson TF
    Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  111. MCCARTHY MW, Kontoyiannis DP, Cornely OA, Perfect JR, et al
    Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  112. PERLIN DS, Wiederhold NP
    Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  113. MCCARTHY MW, Denning DW, Walsh TJ
    Future Research Priorities in Fungal Resistance.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  114. NIELSEN TB, Pantapalangkoor P, Luna BM, Bruhn KW, et al
    Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
    J Infect Dis. 2017;216:489-501.
    PubMed     Abstract available


  115. CLUTTER DS, Zhou S, Varghese V, Rhee SY, et al
    Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing.
    J Infect Dis. 2017;216:387-391.
    PubMed     Abstract available


    July 2017
  116. GOLDEN MR, Workowski KA, Bolan G
    Developing a Public Health Response to Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  117. MARTIN DH, Manhart LE, Workowski KA
    Mycoplasma genitalium From Basic Science to Public Health: Summary of the Results From a National Institute of Allergy and Infectious Disesases Technical Consultation and Consensus Recommendations for Future Research Priorities.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  118. HORNER PJ, Martin DH
    Mycoplasma genitalium Infection in Men.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  119. BRADSHAW CS, Jensen JS, Waites KB
    New Horizons in Mycoplasma genitalium Treatment.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  120. GAYDOS CA
    Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  121. BOUCHER HW, Ambrose PG, Chambers HF, Ebright RH, et al
    White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs.
    J Infect Dis. 2017;216:228-236.
    PubMed     Abstract available


    June 2017
  122. GODFREY C, Thigpen MC, Crawford KW, Jean-Phillippe P, et al
    Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed    


  123. LAVERDE D, Probst I, Romero-Saavedra F, Kropec A, et al
    Targeting Type IV Secretion System Proteins to Combat Multidrug-Resistant Gram-positive Pathogens.
    J Infect Dis. 2017;215:1836-1845.
    PubMed     Abstract available


    May 2017
  124. JAMMAL J, Zaknoon F, Kaneti G, Hershkovits AS, et al
    Sensitization of Gram-Negative Bacilli to Host Antibacterial Proteins.
    J Infect Dis. 2017;215:1599-1607.
    PubMed     Abstract available


  125. POPOVICH KJ, Snitkin ES, Hota B, Green SJ, et al
    Genomic and Epidemiological Evidence for Community Origins of Hospital-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    J Infect Dis. 2017 May 9. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  126. HAGE E, Wilkie GS, Linnenweber-Held S, Dhingra A, et al
    Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole genomic sequencing directly from clinical specimens.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  127. KAKIUCHI S, Tsuji M, Nishimura H, Yoshikawa T, et al
    Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    J Infect Dis. 2017;215:865-873.
    PubMed     Abstract available


  128. MARGOT NA, Wong P, Kulkarni R, White K, et al
    Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.
    J Infect Dis. 2017;215:920-927.
    PubMed     Abstract available


  129. MAVE V, Chandanwale A, Kagal A, Khadse S, et al
    High Burden of Antimicrobial Resistance and Mortality Among Adults and Children with Community-Onset Bacterial Infections in India.
    J Infect Dis. 2017 Mar 3. doi: 10.1093.
    PubMed     Abstract available


  130. OECHSLIN F, Piccardi P, Mancini S, Gabard J, et al
    Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
    J Infect Dis. 2017;215:703-712.
    PubMed     Abstract available


    February 2017
  131. RAY SM
    Preventing Methicillin-Resistant Staphylococcus aureus (MRSA) Disease in Urban US Hospitals-Now for the Hard Part: More Evidence Pointing to the Community as the Source of MRSA Acquisition.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed    


  132. PHILLIPS AN, Stover J, Cambiano V, Nakagawa F, et al
    Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa.
    J Infect Dis. 2017 Feb 17. doi: 10.1093.
    PubMed     Abstract available


  133. GEISINGER E, Isberg RR
    Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


  134. GOMEZ-SIMMONDS A, Uhlemann AC
    Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


  135. LOGAN LK, Weinstein RA
    The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


  136. MURRAY GL, Tsyganov K, Kostoulias XP, Bulach DM, et al
    Global Gene Expression Profile of Acinetobacter baumannii During Bacteremia.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


  137. PARKER D
    Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


  138. HENRY CS, Rotman E, Lathem WW, Tyo KE, et al
    Generation and Validation of the iKp1289 Metabolic Model for Klebsiella pneumoniae KPPR1.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


  139. AHN D, Prince A
    Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


  140. JUAN C, Pena C, Oliver A
    Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.
    J Infect Dis. 2017;215.
    PubMed     Abstract available


    December 2016
  141. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.
    J Infect Dis. 2016;214:1826-1830.
    PubMed     Abstract available


    November 2016
  142. GUNTHARD HF, Scherrer AU
    HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance.
    J Infect Dis. 2016;214:1289-1291.
    PubMed    


    September 2016
  143. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Abstract available


  144. GRAD YH, Harris SR, Kirkcaldy RD, Green AG, et al
    Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013.
    J Infect Dis. 2016.
    PubMed     Abstract available


    July 2016
  145. DOSTER RS, Kirk L, Tetz LM, Rogers LM, et al
    Staphylococcus aureus infection of human gestational membranes induces bacterial biofilm formation and host production of cytokines.
    J Infect Dis. 2016.
    PubMed     Abstract available


    May 2016
  146. WHITE E, Smit E, Churchill D, Collins S, et al
    No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.
    J Infect Dis. 2016.
    PubMed     Abstract available


    March 2016
  147. LANIER ER, Foster S, Brundage T, Chou S, et al
    Analysis of Cytomegalovirus DNA Polymerase Gene Mutations in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.
    J Infect Dis. 2016.
    PubMed     Abstract available


    February 2016
  148. ARAGRI M, Alteri C, Battisti A, Di Carlo D, et al
    Multiple HBV Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B.
    J Infect Dis. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: